Azadmanesh J, Slobodnik K, Struble L, Lutz W, Coates L, Weiss K
Nat Commun. 2024; 15(1):5973.
PMID: 39013847
PMC: 11252399.
DOI: 10.1038/s41467-024-50260-w.
Borgstahl G, Azadmanesh J, Slobodnik K, Struble L, Lutz W, Coates L
Res Sq. 2024; .
PMID: 38405788
PMC: 10889052.
DOI: 10.21203/rs.3.rs-3880128/v1.
Sorolla M, Hidalgo I, Sorolla A, Montal R, Pallise O, Salud A
Cancers (Basel). 2021; 13(20).
PMID: 34680186
PMC: 8534037.
DOI: 10.3390/cancers13205037.
Larue L, Myrzakhmetov B, Ben-Mihoub A, Moussaron A, Thomas N, Arnoux P
Pharmaceuticals (Basel). 2019; 12(4).
PMID: 31671658
PMC: 6958374.
DOI: 10.3390/ph12040163.
Mauney C, Rogers L, Harris R, Daniel L, Devarie-Baez N, Wu H
Antioxid Redox Signal. 2017; 27(16):1317-1331.
PMID: 28398823
PMC: 5655415.
DOI: 10.1089/ars.2016.6888.
RA Differentiation Enhances Dopaminergic Features, Changes Redox Parameters, and Increases Dopamine Transporter Dependency in 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells.
Lopes F, Lisboa da Motta L, De Bastiani M, Pfaffenseller B, Aguiar B, de Souza L
Neurotox Res. 2017; 31(4):545-559.
PMID: 28155214
DOI: 10.1007/s12640-016-9699-0.
Reprogramming human A375 amelanotic melanoma cells by catalase overexpression: Upregulation of antioxidant genes correlates with regression of melanoma malignancy and with malignant progression when downregulated.
Bracalente C, Ibanez I, Berenstein A, Notcovich C, Cerda M, Klamt F
Oncotarget. 2016; 7(27):41154-41171.
PMID: 27206673
PMC: 5173049.
DOI: 10.18632/oncotarget.9273.
Reprogramming human A375 amelanotic melanoma cells by catalase overexpression: Reversion or promotion of malignancy by inducing melanogenesis or metastasis.
Bracalente C, Salguero N, Notcovich C, Muller C, da Motta L, Klamt F
Oncotarget. 2016; 7(27):41142-41153.
PMID: 27206672
PMC: 5173048.
DOI: 10.18632/oncotarget.9220.
In vitro evaluation of antitumoral efficacy of catalase in combination with traditional chemotherapeutic drugs against human lung adenocarcinoma cells.
de Oliveira V, Lisboa da Motta L, De Bastiani M, Lopes F, Muller C, Gabiatti B
Tumour Biol. 2016; 37(8):10775-84.
PMID: 26873489
DOI: 10.1007/s13277-016-4973-6.
Hydrogen peroxide - production, fate and role in redox signaling of tumor cells.
Lennicke C, Rahn J, Lichtenfels R, Wessjohann L, Seliger B
Cell Commun Signal. 2015; 13:39.
PMID: 26369938
PMC: 4570748.
DOI: 10.1186/s12964-015-0118-6.
Oxidative stress associates with aggressiveness in lung large-cell carcinoma.
Lisboa da Motta L, De Bastiani M, Stapenhorst F, Klamt F
Tumour Biol. 2015; 36(6):4681-8.
PMID: 25638031
DOI: 10.1007/s13277-015-3116-9.
Enhancement of ionizing radiation response by histamine in vitro and in vivo in human breast cancer.
Martinel Lamas D, Cortina J, Ventura C, Sterle H, Valli E, Balestrasse K
Cancer Biol Ther. 2014; 16(1):137-48.
PMID: 25482934
PMC: 4622567.
DOI: 10.4161/15384047.2014.987091.
Superoxide dismutases and superoxide reductases.
Sheng Y, Abreu I, Cabelli D, Maroney M, Miller A, Teixeira M
Chem Rev. 2014; 114(7):3854-918.
PMID: 24684599
PMC: 4317059.
DOI: 10.1021/cr4005296.
Imbalance in redox status is associated with tumor aggressiveness and poor outcome in lung adenocarcinoma patients.
Lisboa da Motta L, Muller C, De Bastiani M, Behr G, Franca F, da Rocha R
J Cancer Res Clin Oncol. 2014; 140(3):461-70.
PMID: 24449404
DOI: 10.1007/s00432-014-1586-6.
Phosphorylation and subcellular localization of p27Kip1 regulated by hydrogen peroxide modulation in cancer cells.
Ibanez I, Bracalente C, Notcovich C, Tropper I, Molinari B, Policastro L
PLoS One. 2012; 7(9):e44502.
PMID: 22970236
PMC: 3435274.
DOI: 10.1371/journal.pone.0044502.
Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy.
Gupta S, Hevia D, Patchva S, Park B, Koh W, Aggarwal B
Antioxid Redox Signal. 2011; 16(11):1295-322.
PMID: 22117137
PMC: 3324815.
DOI: 10.1089/ars.2011.4414.
Ets-1 regulates energy metabolism in cancer cells.
Verschoor M, Wilson L, Verschoor C, Singh G
PLoS One. 2010; 5(10):e13565.
PMID: 21042593
PMC: 2962648.
DOI: 10.1371/journal.pone.0013565.
Suppression of cancer growth by nonviral gene therapy based on a novel reactive oxygen species-responsive promoter.
Policastro L, Ibanez I, Duran H, Soria G, Gottifredi V, Podhajcer O
Mol Ther. 2009; 17(8):1355-64.
PMID: 19436270
PMC: 2835249.
DOI: 10.1038/mt.2009.103.
Regulation of late G1/S phase transition and APC Cdh1 by reactive oxygen species.
Havens C, Ho A, Yoshioka N, Dowdy S
Mol Cell Biol. 2006; 26(12):4701-11.
PMID: 16738333
PMC: 1489138.
DOI: 10.1128/MCB.00303-06.
Effect of superoxide dismutase and malondialdehyde metabolic changes on carcinogenesis of gastric carcinoma.
Wang S, Wang Y, Zhang K, Shen J, Zhou H, Qiu X
World J Gastroenterol. 2005; 11(28):4305-10.
PMID: 16038025
PMC: 4434653.
DOI: 10.3748/wjg.v11.i28.4305.